Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes.
Ohe C, Yoshida T, Ikeda J, Tsuzuki T, Ohashi R, Ohsugi H, Atsumi N, Yamaka R, Saito R, Yasukochi Y, Higasa K, Kinoshita H, Tsuta K. Ohe C, et al. Among authors: higasa k. Biomedicines. 2022 Jan 29;10(2):323. doi: 10.3390/biomedicines10020323. Biomedicines. 2022. PMID: 35203532 Free PMC article.
Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.
Ohe C, Yoshida T, Amin MB, Atsumi N, Ikeda J, Saiga K, Noda Y, Yasukochi Y, Ohashi R, Ohsugi H, Higasa K, Kinoshita H, Tsuta K. Ohe C, et al. Among authors: higasa k. Mod Pathol. 2022 Jun;35(6):816-824. doi: 10.1038/s41379-021-00982-9. Epub 2021 Nov 30. Mod Pathol. 2022. PMID: 34848832 Free article.
Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.
Ohe C, Yoshida T, Amin MB, Atsumi N, Ikeda J, Saiga K, Noda Y, Yasukochi Y, Ohashi R, Ohsugi H, Higasa K, Kinoshita H, Tsuta K. Ohe C, et al. Among authors: higasa k. Mod Pathol. 2022 May;35(5):708. doi: 10.1038/s41379-021-01006-2. Mod Pathol. 2022. PMID: 35027650 Free article. No abstract available.
PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma.
Saiga K, Ohe C, Yoshida T, Ohsugi H, Ikeda J, Atsumi N, Noda Y, Yasukochi Y, Higasa K, Taniguchi H, Kinoshita H, Tsuta K. Saiga K, et al. Among authors: higasa k. Cancers (Basel). 2022 Feb 20;14(4):1062. doi: 10.3390/cancers14041062. Cancers (Basel). 2022. PMID: 35205810 Free PMC article.
Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M. Abou-Taleb H, et al. Among authors: higasa k. Oncotarget. 2016 Aug 23;7(34):54758-54770. doi: 10.18632/oncotarget.10181. Oncotarget. 2016. PMID: 27340867 Free PMC article.
Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.
Murakami R, Matsumura N, Brown JB, Higasa K, Tsutsumi T, Kamada M, Abou-Taleb H, Hosoe Y, Kitamura S, Yamaguchi K, Abiko K, Hamanishi J, Baba T, Koshiyama M, Okuno Y, Yamada R, Matsuda F, Konishi I, Mandai M. Murakami R, et al. Among authors: higasa k. Am J Pathol. 2017 Oct;187(10):2246-2258. doi: 10.1016/j.ajpath.2017.06.012. Epub 2017 Sep 6. Am J Pathol. 2017. PMID: 28888422 Free article.
86 results